The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma
Open accessPreprint — published as 10.1016/j.molcel.2025.05.030 · Paper page
Abstract
Summary: The midnolin-proteasome pathway degrades many nuclear proteins without ubiquitination, but how it operates mechanistically remains unclear. Here, we present structures of the midnolin-proteasome complex, revealing how established proteasomal components are repurposed to enable a unique form of proteolysis. While the proteasomal subunit PSMD2/Rpn1 binds to ubiquitinated or ubiquitin-like proteins, we discover that it also interacts with the midnolin nuclear localization sequence, elucidating how midnolin’s activity is confined to the nucleus. Likewise, PSMD14/Rpn11, an enzyme that normally cleaves ubiquitin chains, surprisingly functions non-enzymatically as a receptor for the midnolin ubiquitin-like (Ubl) domain, positioning the substrate-binding Catch domain directly above the proteasomal entry site to guide substrates into the proteasome. Moreover, we demonstrate that midnolin downregulation is critical for the survival of myeloma cells by promoting the expression of its transcription factor substrate IRF4. Our findings uncover the mechanisms underlying the midnolin-proteasome pathway and midnolin downregulation as a driver of multiple myeloma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Flagged first, then by citations
Research works printed but not linked: 60
- 10.1038/nm.3739 · DOI
- 10.1042/BST20191094 · DOI
- 10.1146/annurev-biochem-062917-011931 · DOI
- 10.1016/S0092-8674(00)80843-0 · DOI
- 10.1126/science.adh5021 · DOI
- 10.1016/j.devcel.2016.05.013 · DOI
- 10.1016/j.neuron.2018.10.013 · DOI · Paper page
- 10.1161/CIRCRESAHA.111.253377 · DOI
- 10.3390/cells8111373 · DOI
- 10.1038/s41580-021-00341-1 · DOI
- 10.1038/ni1357 · DOI
- 10.1038/nature07064 · DOI · Paper page
- 10.1152/ajpgi.00011.2023 · DOI
- 10.1038/ncb845 · DOI
- 10.1074/jbc.M404020200 · DOI
- 10.1038/nature06926 · DOI
- 10.1126/science.aad9421 · DOI
- 10.1016/j.molcel.2008.03.004 · DOI
- 10.1126/science.1075898 · DOI
- 10.1038/nature01071 · DOI
- 10.1038/nsmb.2771 · DOI
- 10.1038/nsmb.2616 · DOI · Paper page
- 10.1016/j.molcel.2023.07.023 · DOI
- 10.1126/science.aav0725 · DOI
- 10.1038/s41586-018-0736-4 · DOI · Paper page
- 10.1016/j.jbc.2021.101052 · DOI
- 10.1016/j.str.2016.05.018 · DOI
- 10.1038/s41586-022-04671-8 · DOI
- 10.1101/2021.10.04.463034 · DOI · Paper page
- 10.1126/science.abi6983 · DOI · Paper page
- 10.1038/20367 · DOI
- 10.1083/jcb.131.6.1699 · DOI
- 10.1016/0092-8674(95)90331-3 · DOI
- 10.1074/jbc.M209037200 · DOI
- 10.1038/s41586-024-07487-w · DOI · Paper page
- 10.1126/science.1160489 · DOI · Paper page
- 10.1126/science.1160462 · DOI
- 10.1038/s41559-020-01327-6 · DOI
- 10.1182/blood-2014-11-568881 · DOI
- 10.1038/s43018-023-00550-x · DOI
- 10.1016/j.cell.2017.06.010 · DOI · Paper page
- 10.1182/blood.2022016892 · DOI
- 10.1093/nar/gkaa1100 · DOI · Paper page
- 10.15252/embr.201947910 · DOI
- 10.1084/jem.20232132 · DOI
- 10.1038/s41572-024-00529-7 · DOI
- 10.1016/j.molcel.2022.12.013 · DOI
- 10.1016/j.jsb.2005.07.007 · DOI
- 10.1038/nmeth.4169 · DOI · Paper page
- 10.1107/S2059798319011471 · DOI · Paper page
- 10.1107/S0907444910007493 · DOI · Paper page
- 10.1107/S0907444909047337 · DOI · Paper page
- 10.1107/S0021889807021206 · DOI · Paper page
- 10.1038/nmeth.1896 · DOI · Paper page
- 10.1002/pro.4792 · DOI
- 10.1038/s41586-024-07215-4 · DOI · Paper page
- 10.1021/bi061994u · DOI · Paper page
- 10.1073/pnas.1902931116 · DOI
- 10.1021/acs.jproteome.7b00913 · DOI
- 10.1002/pmic.201200439 · DOI · Paper page
Metadata
- Authors
- Nardone, C., Gao, J., Seo, H.-S., Mintseris, J., Ort, L., Yip, M. C. J., Negasi, M., Besschetnova, A. K., Kamitaki, N., Gygi, S. P., Dhe-Paganon, S., Munshi, N., Fulciniti, M., Greenberg, M. E., Shao, S., Elledge, S. J., & Gu, X.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Dana-Farber Cancer Institute (US)
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA
- VA Boston Healthcare System (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Shao, Sichen
- Elledge, Stephen J.
- Gu, Xin
- ORCID
- Venue
- Molecular Cell
- Publisher
- openRxiv
- Published
- 2025-02-23
- Volume
- 85
- Issue
- 13
- Pages
- 2597-2609.e11
- ISSN
- 1097-2765 (ISSN-L)
- PMC
- PMC12291620
- OpenAlex
- W4411370036
- Cited by
- 22
- References
- 1
- Citations by year
- 2026: 15 · 2025: 7
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Science Foundation
- David and Lucile Packard Foundation
- Howard Hughes Medical Institute
- American Heart Association (287375208)
- Damon Runyon Cancer Research Foundation (DRG-2469-22)
- National Institutes of Health (R01073277, GM97645, CA155258-10)
- National Institute on Aging (R01AG073277, R01AG011085)
- National Heart, Lung, and Blood Institute (R01HL177823)
- National Human Genome Research Institute (T32HG002295)
- National Cancer Institute (P01CA155258)
- National Institute of Neurological Disorders and Stroke (R01NS115965)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Keywords
- proteasome, multiple myeloma, ubiquitin-like proteins, nuclear localization signal, transcription factor degradation, proteasome structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review